PATENT CLAIM ANALYSIS

Application Number: 15765824
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "04400A"]

Abstract:
Disclosed are methods of treating a head and/or neck squamous cell carcinoma in an individual. The method may include the step of administering to an individual a composition comprising an interleukin-1 receptor-associated kinase 1 (IRAK1) inhibitor, which may include inhibitors that inhibit IL-1 receptor-associated kinase 1 in addition to other IL-1 receptor-associated kinases, such as, for example, an IRAK1/4 inhibitor.

Claim (Index 2):
The method of  claim 1 , wherein said head and/or neck squamous cell carcinoma is characterized by DEK overexpression.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 91.0
- Lexical Diversity: 1.41667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14284521', '15288402', '14842049', '14604310', '14367837']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7626773426358421
- 35 USC 102 Novelty (BERT): 0.5150576374857834
- Combined Prediction Score: 0.7379153721208361
- Mean Citation Score: 214.531664
- Max Citation Score: 223.97466
- Similarity Product: 123.05120467664122

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test